TD Waterhouse Canada’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $14.6K | Sell |
599
-523
| -47% | -$12.7K | ﹤0.01% | 1374 |
|
2025
Q1 | $22.6K | Sell |
1,122
-325
| -22% | -$6.55K | ﹤0.01% | 1243 |
|
2024
Q4 | $34.1K | Sell |
1,447
-11
| -0.8% | -$259 | ﹤0.01% | 1168 |
|
2024
Q3 | $36.2K | Sell |
1,458
-97
| -6% | -$2.41K | ﹤0.01% | 1114 |
|
2024
Q2 | $36.6K | Sell |
1,555
-1,885
| -55% | -$44.3K | ﹤0.01% | 1089 |
|
2024
Q1 | $110K | Sell |
3,440
-383
| -10% | -$12.2K | ﹤0.01% | 884 |
|
2023
Q4 | $129K | Sell |
3,823
-3,619
| -49% | -$122K | ﹤0.01% | 754 |
|
2023
Q3 | $215K | Sell |
7,442
-4,849
| -39% | -$140K | ﹤0.01% | 631 |
|
2023
Q2 | $435K | Sell |
12,291
-2,100
| -15% | -$74.4K | ﹤0.01% | 558 |
|
2023
Q1 | $440K | Buy |
14,391
+312
| +2% | +$9.54K | ﹤0.01% | 547 |
|
2022
Q4 | $395K | Sell |
14,079
-5,328
| -27% | -$149K | ﹤0.01% | 559 |
|
2022
Q3 | $651K | Buy |
19,407
+4,500
| +30% | +$151K | 0.01% | 468 |
|
2022
Q2 | $474K | Sell |
14,907
-18,895
| -56% | -$601K | 0.01% | 546 |
|
2022
Q1 | $1.64M | Sell |
33,802
-5,480
| -14% | -$266K | 0.02% | 372 |
|
2021
Q4 | $2.44M | Buy |
+39,282
| New | +$2.44M | 0.02% | 339 |
|